# First Solar, Inc.: overview

FSLR · Nasdaq · CIK 1274494 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fslr.md) · [Financials](/companies/fslr/financials.md) · [Filings](/companies/fslr/filings.md) · [Insiders](/companies/fslr/insiders.md)

Latest reported revenue: [$1.23bn](/filings/0001274494-26-000212.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001274494-26-000212).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,514 d](/filings/0001274494-26-000021.md) | [845](/filings/0001274494-26-000109.md) | [1,097](/filings/0001274494-26-000170.md) | [1,595](/filings/0001274494-26-000212.md) | [1,683 d](/filings/0001274494-26-000021.md) | [1,044](/filings/0001274494-26-000109.md) | [1,056](/filings/0001274494-26-000170.md) | [1,231](/filings/0001274494-26-000212.md) |
| Gross margin | % | [37.5% d](/filings/0001274494-26-000021.md) | [40.8%](/filings/0001274494-26-000109.md) | [45.6%](/filings/0001274494-26-000170.md) | [38.3%](/filings/0001274494-26-000212.md) | [39.5% d](/filings/0001274494-26-000021.md) | [46.6%](/filings/0001274494-26-000109.md) | [57.3%](/filings/0001274494-26-000170.md) | [57.9%](/filings/0001274494-26-000212.md) |
| Operating margin | % | [30.2% d](/filings/0001274494-26-000021.md) | [26.2%](/filings/0001274494-26-000109.md) | [33.0%](/filings/0001274494-26-000170.md) | [29.2%](/filings/0001274494-26-000212.md) | [32.6% d](/filings/0001274494-26-000021.md) | [33.1%](/filings/0001274494-26-000109.md) | [42.6%](/filings/0001274494-26-000170.md) | [44.4%](/filings/0001274494-26-000212.md) |
| Net margin | % | [26.0% d](/filings/0001274494-26-000021.md) | [24.8%](/filings/0001274494-26-000109.md) | [31.2%](/filings/0001274494-26-000170.md) | [28.6%](/filings/0001274494-26-000212.md) | [31.0% d](/filings/0001274494-26-000021.md) | [33.2%](/filings/0001274494-26-000109.md) | [40.0%](/filings/0001274494-26-000170.md) | [46.4%](/filings/0001274494-26-000212.md) |
| Diluted EPS | $ per share | not reported | [1.95](/filings/0001274494-26-000109.md) | [3.18](/filings/0001274494-26-000170.md) | [4.24](/filings/0001274494-26-000212.md) | not reported | [3.22](/filings/0001274494-26-000109.md) | [3.92](/filings/0001274494-26-000170.md) | [5.30](/filings/0001274494-26-000212.md) |
| Free cash flow | $m | [497 d](/filings/0001274494-26-000021.md) | [(814)](/filings/0001274494-26-000109.md) | [(139) d](/filings/0001274494-26-000170.md) | [1,070 d](/filings/0001274494-26-000212.md) | [1,070 d](/filings/0001274494-26-000021.md) | [(333)](/filings/0001274494-26-000109.md) | [(306) d](/filings/0001274494-26-000170.md) | [(198) d](/filings/0001274494-26-000212.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,923](/filings/0001274494-24-000004.md) | [2,619](/filings/0001274494-25-000010.md) | [3,319](/filings/0001274494-26-000021.md) | [4,206](/filings/0001274494-26-000021.md) | [5,219](/filings/0001274494-26-000021.md) |
| Gross margin | % | [25.0%](/filings/0001274494-24-000004.md) | [2.7%](/filings/0001274494-25-000010.md) | [39.2%](/filings/0001274494-26-000021.md) | [44.2%](/filings/0001274494-26-000021.md) | [40.6%](/filings/0001274494-26-000021.md) |
| Operating margin | % | [20.1%](/filings/0001274494-24-000004.md) | [(1.0%)](/filings/0001274494-25-000010.md) | [25.8%](/filings/0001274494-26-000021.md) | [33.2%](/filings/0001274494-26-000021.md) | [30.6%](/filings/0001274494-26-000021.md) |
| Net margin | % | [16.0%](/filings/0001274494-24-000004.md) | [(1.7%)](/filings/0001274494-25-000010.md) | [25.0%](/filings/0001274494-26-000021.md) | [30.7%](/filings/0001274494-26-000021.md) | [29.3%](/filings/0001274494-26-000021.md) |
| Diluted EPS | $ per share | [4.38](/filings/0001274494-24-000004.md) | [(0.41)](/filings/0001274494-25-000010.md) | [7.74](/filings/0001274494-26-000021.md) | [12.02](/filings/0001274494-26-000021.md) | [14.21](/filings/0001274494-26-000021.md) |
| Free cash flow | $m | [(303)](/filings/0001274494-24-000004.md) | [(30.2)](/filings/0001274494-25-000010.md) | [(785)](/filings/0001274494-26-000021.md) | [(308)](/filings/0001274494-26-000021.md) | [1,187](/filings/0001274494-26-000021.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fslr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.31bn | 14,029,065 |  | Added +207,989 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.74bn | 7,369,400 | Call | Added +1,688,100 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.61bn | 6,836,941 |  | Added +48,007 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.33bn | 5,638,446 |  | Reduced −58,442 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.32bn | 5,576,026 |  | Added +291,409 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.29bn | 5,484,100 | Call | Added +686,800 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.24bn | 5,243,400 | Put | Reduced −422,600 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.12bn | 4,758,900 | Put | Reduced −185,200 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.05bn | 4,435,400 | Call | Added +520,900 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $970.9m | 4,114,639 |  | New +4,114,639 |

## Recent filings

[All 2,291 filings](/companies/fslr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:06 ET | [10-Q](/filings/0001274494-26-000212.md) | Quarterly report, period 2026-09-30 | 0001274494-26-000212 |
| 2026-10-29 | 16:03 ET | [8-K](/filings/0001274494-26-000211.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274494-26-000211 |
| 2026-07-30 | 16:06 ET | [10-Q](/filings/0001274494-26-000170.md) | Quarterly report, period 2026-06-30 | 0001274494-26-000170 |
| 2026-07-30 | 16:04 ET | [8-K](/filings/0001274494-26-000169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274494-26-000169 |
| 2026-05-15 | 16:02 ET | [8-K](/filings/0001274494-26-000138.md) | 5.07 Shareholder vote results | 0001274494-26-000138 |
| 2026-04-30 | 16:05 ET | [10-Q](/filings/0001274494-26-000109.md) | Quarterly report, period 2026-03-31 | 0001274494-26-000109 |
| 2026-04-30 | 16:04 ET | [8-K](/filings/0001274494-26-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274494-26-000108 |
| 2026-04-02 | 16:01 ET | [DEF 14A](/filings/0001274494-26-000096.md) | Proxy statement, period 2026-04-02 | 0001274494-26-000096 |
| 2026-02-24 | 16:12 ET | [10-K](/filings/0001274494-26-000021.md) | Annual report, period 2025-12-31 | 0001274494-26-000021 |
| 2026-02-24 | 16:09 ET | [8-K](/filings/0001274494-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274494-26-000020 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001274494-26-000021.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/417d06c6-3288-4d8a-b218-cea98ead2d99)

## About the filer

- CIK: 1274494
- Tickers: FSLR
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:13 ET. No prices; not investment advice.